Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. Bonnefond, A.; Yengo, L.; Philippe, J.; Dechaume, A.; Ezzidi, I.; Vaillant, E.; Gjesing, A. P.; Andersson, E. A.; Czernichow, S.; Hercberg, S.; Hadjadj, S.; Charpentier, G.; Lantieri, O.; Balkau, B.; Marre, M.; Pedersen, O.; Hansen, T.; Froguel, P.; Vaxillaire, M.. Diabetologia. 2013; 56: p.492-496. doi:10.1007/s00125-012-2794-8Article
Épidémiologie clinique